No Data
No Data
Simcere Pharma Schedules Key Financial Review Meeting
Simcere Pharma (02096.HK) held a board of directors meeting on August 21 to consider and approve interim performance.
Simcere Pharma (02096.HK) announced that the board of directors meeting will be held on August 21, 2024 (Wednesday) to consider and approve the unaudited interim performance of the company and its subsidiaries for the six months ending on June 30, 2024, and to consider recommending the distribution of interim dividends (if any).
SIMCERE PHARMA: DATE OF BOARD MEETING
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
Hong Kong stock concept tracking | WHO: Summer COVID-19 resurgence is not ruled out, inflow of funds into the biomedical sector (with concept stocks).
WHO: COVID-19 infection rate is soaring in summer, and the possibility of recurrence cannot be ruled out.
CICC: The pharmaceutical sector has entered a value investment range, focusing on the domestic innovative drug industry chain and going overseas.
China International Capital Corporation released a research report stating that after three years of systematic adjustment, the pharmaceutical sector has entered the range of value investment.
No Data